An IgE receptor mimetic peptide (PepE) protects mice from IgE mediated anaphylaxis(350 views visite) Zhou JS, Sandomenico A, Burton O, Oettgen HC, Ruvo M
Keywords Parole chiave: Immunoglobulin E, Immunoglobulin E Receptor, Peptide, Protein Binding, Amino Acid Sequence, Anaphylaxis, Animal, Chemistry, Disease Model, Female, Genetics, Immunology, Knockout Mouse, Metabolism, Molecular Mimicry, Article, Time Factors, Anaphylaxis Genetics Immunology Prevention, Control, Immunoglobulin E Genetics Immunology Metabolism, Peptides Administration, Dosage Chemistry Pharmacology, Protein Binding Immunology, Ige Chemistry,
Affiliations Affiliazioni: *** IBB - CNR ***
Boston Children's Hospital, Boston MA 02115, United States Boston Medical Center, Boston University School of Medicine, Boston MA 02118, United States Istituto di Biostrutture e Bioimmagini, CNR, Centro Interuniversitario di Ricerca sui Peptidi Bioattivi (CIRPeB), via Mezzocannone 16, I-80134 Naples, Italy Seconda Università di Napoli, via Vivaldi 43, Caserta Napoli, Italy Seconda Universit di Napoli, via Vivaldi 43, Caserta Napoli, Italy
Helm, B., Kebo, D., Vercelli, D., Glovsky, M.M., Gould, H., Ishizaka, K., Geha, R., Ishizaka, T., (1989) Proc. Natl. Acad. Sci. U. S. A., 86, pp. 9465-9469
Sandomenico, A., Monti, S.M., Marasco, D., Dathan, N., Palumbo, R., Saviano, M., Ruvo, M., (2009) Mol. Immunol., 46, pp. 3300-3309
Mathias, C.B., Hobson, S.A., Garcia-Lloret, M., Lawson, G., Poddighe, D., Freyschmidt, E.J., Xing, W., Oettgen, H.C., (2011) J. Allergy Clin. Immunol., 127, pp. 795-805. , e791-e796
Fields, G.B., Noble, R.L., (1990) Int. J. Pept. Protein Res., 35, pp. 161-214
Oettgen, H.C., Martin, T.R., Wynshaw-Boris, A., Deng, C., Drazen, J.M., Leder, P., (1994) Nature, 370, pp. 367-370
Hayashi, N., Tsukamoto, Y., Sallas, W.M., Lowe, P.J., (2007) Br. J. Clin. Pharmacol., 63, pp. 548-561
Bedoret, D., Singh, A.K., Shaw, V., Hoyte, E.G., Hamilton, R., Dekruyff, R.H., Schneider, L.C., Umetsu, D.T., (2012) Mucosal Immunol., 5, pp. 267-276
An IgE receptor mimetic peptide (PepE) protects mice from IgE mediated anaphylaxis
Crosslinking of receptor-bound Immunoglobulin E (IgE) triggers immediate hypersensitivity reactions including anaphylaxis. Blocking the interaction of IgE with its high-affinity receptor, FceRI, on mast cells and basophils is an attractive strategy for the treatment of allergies. This approach has seen clinical success using the anti-IgE monoclonal antibody, omalizumab. We recently designed and characterized a novel FceRI-mimetic peptide (PepE) which contains the two key FceRI alpha-chain receptor loops known to interact with the e-heavy chain of IgE, C'-E and B-C, with an optimized linker for joining them. PepE has high specificity and affinity for IgE, blocks IgE binding to FceRI and prevents IgE-induced mediator release from RBL2H3 cells. We have now investigated the biological effects of this peptide in vivo using a line of mice (BALB/c Il4raF709) very sensitive to IgE-mediated systemic anaphylaxis. IgE-deficient (IgE(-/-)) Il4raF709 mice were passively sensitized with the anti-DNP IgE monoclonal antibody (SPE-7) and subsequently challenged i. v. with DNP-BSA. Mice receiving a single dose of PepE prior to sensitization with SPE-7 IgE were fully protected from anaphylaxis while vehicle control-treated mice displayed strong reactions with significant core body temperature drops and elevated levels of mouse mast cell protease-1 (mMCP-1) in the serum. However, PepE had no effect on IgE-mediated anaphylaxis if given after IgE administration in IgE(-/-) mice, suggesting that PepE can block binding of free IgE to FceRI but cannot compete with the receptor for already bound IgE in vivo. A single dose of PepE treatment did not protect IgE sufficient mice from IgE mediated anaphylaxis. However, a 3 week long course of PepE treatment protected IgE sufficient Il4raF709 mice from body temperature drops and elevation of serum mMCP-1. Our findings establish the potential of this type of structure for blocking IgE binding to mast cells in vivo and suggest that related peptides might have the potential to attenuate clinical allergic reactions.
An IgE receptor mimetic peptide (PepE) protects mice from IgE mediated anaphylaxis
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(191 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(207 visite) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 DettagliEsporta in BibTeXEsporta in EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(277 visite) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 DettagliEsporta in BibTeXEsporta in EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(402 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote